Adi Nagler
Rehovot, M 76100, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Translation dysregulation in cancer as a source for targetable antigens.
Journal: Cancer cell
Published: June 19, 2024
Mechanisms of immune activation and regulation: lessons from melanoma.
Journal: Nature reviews. Cancer
Published: January 04, 2022
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.
Journal: Cell reports
Published: November 03, 2020
Identification of bacteria-derived HLA-bound peptides in melanoma.
Journal: Nature
Published: November 04, 2019
Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma.
Journal: Oncotarget
Published: March 14, 2019
A genome-wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS-mutant melanoma.
Journal: Pigment cell & melanoma research
Published: January 26, 2019
CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma.
Journal: Oncotarget
Published: March 07, 2018
Inhibition of APOBEC3G activity impedes double-stranded DNA repair.
Journal: The FEBS journal
Published: May 14, 2015
Inhibition of matrix metalloproteinase-2 by halofuginone is mediated by the Egr1 transcription factor.
Journal: Anti-cancer drugs
Published: August 14, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026